News

Addition Technology, Inc., the maker of Intacs corneal implants, AlphaSphere orbital implants and the AlphaCor artificial cornea has received FDA approval for an expanded range of additional sizes of Intacs corneal implants for keratoconus.

Carl Zeiss Meditec has announced that ReLEx, the first femtosecond-only method of laser vision correction, is now available for sale outside the United States.1 ReLEx is a new application that allows ophthalmic surgeons to perform a variety of complete laser vision correction procedures using only the VisuMax Femtosecond laser.

Heidelberg Engineering is introducing SPECTRALIS, then office-based imaging device for tracking and measuring axonal change, at the 2010 meeting of the American Academy of Neurology in Toronto.

Highlights from an expert roundtable meeting can be found in the April issue of Ophthalmology Times Europe.

The Review of Ophthalmology recently published a survey amongst surgeons which indicates that toric IOLs are becoming more popular for managing astigmastism in cataract patients. The results also demonstrated a move away from bimanual surgery and the mixing of presbyopic IOLs.

The findings of a case report in Cognitive and Behavioral Neurology may support its authors hypothesis that the primary visual cortex, in which retinal spatial geometry is preserved, is not critical for visual imagery.

Joe Lovett's film, Going Blind will be screened at the World Ophthalmology Congress in Berlin in June. Ophthalmology Times Europe strongly recommends that all doctors put this on their schedule if they are visiting the congress.

Medicare patients in the United States are 5.5 times more likely to get cataract surgery than those who receive their care from the Department of Veterans Affairs, according to a study reported in the March 2010 issue of the American Journal of Medical Quality

> New research from the UK shows that OptiveTM eye drops have a significantly better effect on conjunctival tissues of patients with mild to moderate dry eye compared with Hylocomod (Na-Hyaluronate) eyedrops1, according to a company media statement.